<DOC>
	<DOCNO>NCT00905658</DOCNO>
	<brief_summary>RATIONALE : Learning effect nutritional supplement quality life patient receive chemotherapy cancer may help doctor plan best treatment . PURPOSE : This randomized phase II trial study nutritional supplement see well work improve quality life first-line chemotherapy patient metastatic gynecologic cancer .</brief_summary>
	<brief_title>Nutritional Supplements Improving Quality Life During First-Line Chemotherapy Patients With Metastatic Gynecological Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Measure quality life ( QLQ-C30 ) week 18 patient metastatic gynecological cancer receive systematic nutritional supplement first-line chemotherapy . Secondary - Study maintenance improvement intake nutritional status . - Study quality life chemotherapy . - Evaluate tolerance compliance treatment nutritional supplement . - Evaluate feasibility tolerance chemotherapy . - Measure overall survival 18 week . - Analyze cost-effectiveness different strategy nutritional care . OUTLINE : Patients randomize 1 3 treatment arm . - Arm I : Patients monitor via standard follow-up assessment every 3 week . - Arm II : Patients receive nutritional supplement monitor via standard follow-up assessment every 3 week . - Arm III : Patients receive nutritional supplement monitor via standard follow-up assessment every 3 week additional biweekly assessment complete home service provider .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm gynecological cancer Currently receive firstline chemotherapy metastatic disease PATIENT CHARACTERISTICS : WHO performance status ( PS ) 02 Karnofsky PS 70100 % Not pregnant nurse Intake &lt; 75 % theoretical need Weight loss â‰¥ 5 % within past 6 month No patient dementia alter mental status No psychological , familial , social , geographic situation preclude clinical follow PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent radiotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>ovarian stromal cancer</keyword>
	<keyword>stage IV endometrial carcinoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>stage IVA vaginal cancer</keyword>
	<keyword>stage IVB vaginal cancer</keyword>
	<keyword>stage IV vulvar cancer</keyword>
</DOC>